WO1994019042A1 - Inhalation apparatus - Google Patents

Inhalation apparatus Download PDF

Info

Publication number
WO1994019042A1
WO1994019042A1 PCT/GB1994/000338 GB9400338W WO9419042A1 WO 1994019042 A1 WO1994019042 A1 WO 1994019042A1 GB 9400338 W GB9400338 W GB 9400338W WO 9419042 A1 WO9419042 A1 WO 9419042A1
Authority
WO
WIPO (PCT)
Prior art keywords
passageway
electrodes
dispenser
electrode
charging
Prior art date
Application number
PCT/GB1994/000338
Other languages
French (fr)
Inventor
Wamadeva Balachandran
Chaudhry Nasir Ahmad
Paul Barnes
Original Assignee
Bespak Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bespak Plc filed Critical Bespak Plc
Priority to EP94906960A priority Critical patent/EP0684852A1/en
Publication of WO1994019042A1 publication Critical patent/WO1994019042A1/en

Links

Classifications

    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B5/00Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
    • B05B5/002Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means comprising means for neutralising the spray of charged droplets or particules
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/009Inhalators using medicine packages with incorporated spraying means, e.g. aerosol cans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/02Inhalators with activated or ionised fluids, e.g. electrohydrodynamic [EHD] or electrostatic devices; Ozone-inhalators with radioactive tagged particles
    • BPERFORMING OPERATIONS; TRANSPORTING
    • B05SPRAYING OR ATOMISING IN GENERAL; APPLYING FLUENT MATERIALS TO SURFACES, IN GENERAL
    • B05BSPRAYING APPARATUS; ATOMISING APPARATUS; NOZZLES
    • B05B5/00Electrostatic spraying apparatus; Spraying apparatus with means for charging the spray electrically; Apparatus for spraying liquids or other fluent materials by other electric means
    • B05B5/025Discharge apparatus, e.g. electrostatic spray guns
    • B05B5/053Arrangements for supplying power, e.g. charging power
    • B05B5/0533Electrodes specially adapted therefor; Arrangements of electrodes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M15/00Inhalators
    • A61M15/0065Inhalators with dosage or measuring devices
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M16/00Devices for influencing the respiratory system of patients by gas treatment, e.g. mouth-to-mouth respiration; Tracheal tubes
    • A61M16/0003Accessories therefor, e.g. sensors, vibrators, negative pressure
    • A61M2016/0015Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors
    • A61M2016/0018Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical
    • A61M2016/0021Accessories therefor, e.g. sensors, vibrators, negative pressure inhalation detectors electrical with a proportional output signal, e.g. from a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00Special media to be introduced, removed or treated
    • A61M2202/06Solids
    • A61M2202/064Powder

Definitions

  • This invention relates to inhalation apparatus for dispensing an inhalable substance and in particular but not exclusively to apparatus for use in the delivery of therapeutic substances to the human lung.
  • Medicinal inhalers are well-known and have made a significant contribution to ailments such as asthma. Of particular usefulness are handheld metered dose inhalers and dry powder inhalers. Each produces an aerosol of fine particles containing medicament and which are carried into the respiratory system as the user inhales. Several factors are known to affect the site at which deposition of such airborne particles are deposited in the respiratory system. Recent research has revealed that the electrostatic charge on the particles plays a very important part in determining the site of deposition and it has been shown that the level of electrostatic charge can be used to control specifically the site of deposition.
  • a site may thereby be selected to be higher or lower in the bronchial tree to meet requirements of a particular therapeutic or diagnostic procedure.
  • a level of charge can also serve to reduce the amount of particles lost through exhalation and this is particularly important where small quantities of medicament are to be delivered. It is an object of the present invention to provide an apparatus which provides for an inhalable substance to be dispensed in a manner in which the electrostatic charge on the dispensed particles can be controlled in order to target a specific deposition site in the respiratory tract of the user.
  • apparatus for dispensing an inhalable substance comprising a housing defining a passageway, the housing having a mouth piece defining an inhalation port at one end of the passageway and through which a flow of air from the passageway is inhalable in use, a dispensing means connected to the housing and operable to dispense the substance into the passageway at a dispensing location in the form of inhalable particles and charging means defining a charging region of the passageway located intermediate the inhalation port and the dispensing location the charging means comprising a first electrode having at least one pointed feature having a relatively high curvature and located in the passageway, a second electrode having co-operating features of relatively low curvature and located in the passageway and a charging circuit operable to apply a predetermined voltage between the electrodes such that a predetermined polarity is applied to the first electrode whereby the charging means is operable to impart electrostatic charge of predetermined polarity to the particles passing through the charging region, and wherein the dispensing means
  • a controlled level of electrostatic charge thereby inhaled may represent an increase in electrostatic charge as compared with the inherent level of charge, or it may involve a decrease in the charge, a neutralisation or a charge reversal.
  • Such an arrangement of electrodes results in ionised field charging of particles passing through the charging region.
  • Corona disharge in the vicinity of the high curvature pointed feature of the first electrode results in formation of ions of both polarities, those ions having the same polarity as the first electrode being confined by electrostatic attraction to the immediate vicinity of the first electrode and the ions of opposite polarity tending to migrate towards the second electrode.
  • the migrating ions are hence unipolar and the particles colliding with such ions will acquire electrostatic charge of the same polarity as those ions i.e. the predetermined polarity of the first electrode.
  • the first electrode may comprise a setaceous electrode having a multitude of points.
  • the first electrode may comprise a carbon fibre brush.
  • one or other of the electrodes is centrally located with respect to the passageway and the other of the electrodes being peripherally located with respect to the passageway whereby a radial migration of ions is established in use between the electrodes such that a region traversed by the migrating ions constitutes the charging region.
  • the first electrode may be peripherally located and may constitute a setaceous electrode.
  • the charging circuit may comprise a voltage control circuit operable to control the voltage applied between the electrodes to a predetermined level associated with a required mean level of charge to be imparted in use to the particles.
  • the voltage will lie in the range 1 to 10 kvolts and will be selected according to the electrode geometry and spacing.
  • the charging circuit comprises a timing circuit operable to apply the voltage between the electrodes for a predetermined time interval in response to an actuating signal.
  • the predetermined time interval is selected to be greater than the time taken for the inhalable substance to be dispensed from the dispensing means into the passageway and for subsequent inhalation to be completed.
  • the housing, the charging means and the mouthpiece may if required together constitute an adaptor releasably connectible to the dispensing means.
  • the apparatus may include a breath sensor mounted in the passageway for sensing the inhalation of breath through the passageway and operatively connected to the charging circuit whereby the charging circuit is activated and the voltage is applied to the electrodes in response to inhalation being sensed.
  • the period during which the charging circuit is energised may thereby be kept to a minimum in order to conserve power, this being particularly important where the apparatus is a hand held device including an integral power supply.
  • the dispenser may comprise an electrically operated actuating means which is operatively connected to the breath sensor whereby in use the dispenser is actuated to dispense a dose of the substance in response to inhalation being sensed. This is particularly important when adminstering a substance intended to be deposited deep within the lungs of a patient.
  • the dispensed dose is discharged so as to be inhaled at the beginning of the breath cycle, the typical time during which discharge proceeds being 0.1 to 0.3 seconds for a metered dose inhaler of the pressurised dispenser type. If the dose is released early during inspiration then the probability of the particles reaching the alveolar regions is increased whereas if the release of the dose is during the latter part of the cycle, the particles will tend to be deposited predominantly in the upper airways with much of the dose being lost during exhalation.
  • the additional benefit of modifying the charge associated with the particles provides an additional means of targeting a particular region of the lung. For particles of a given size and type, the preferred net charge per particle can be determined by empirical or modelling techniques and the magnitude and polarity of voltage applied to the electrodes of the apparatus may thereby be adjusted accordingly.
  • the breath sensor comprises a membrane of piezoelectric material supported relative to the housing by a support arranged such that the membrane flexes in response to a change of air presure in the passageway and thereby generates a signal representative of inhalation being sensed.
  • membrane sensors are known from GB-A-2266466.
  • the apparatus may comprise a dispenser which is mechanically actuatable by displacement of an actuating member relative to the housing and may comprise a displacement sensor operatively connected to the charging circuit and responsive to displacement of the actuating member whereby the charging circuit is actuated and the voltage is applied to the electrodes in response to displacement being sensed. Synchronisation between the dispensing of the dose and the charging of the electrodes may thereby be achieved in a straightforward manner.
  • the dispenser comprises a pressurised dispensing container having a dispensing valve stem and a metering valve actuated by relative movement between the valve stem and the container
  • the container may constitute the actuating member and the displacement sensor may comprise a switch responsive to movement of the container relative to the housing.
  • the charging circuit may comprise a timing circuit operable to apply the voltage between the electrodes for a predetermined time interval. This is particularly useful when used in conjunction with a breath sensor of the piezoelectric type where the sensor generates an electrical impulse in response to a change of pressure at the beginning of inhalation rather than a sustained pulse throughout the duration of inhalation.
  • the dispensing means may be operable to dispense particles in the form of liquid droplets or alternatively in the form of a powder.
  • the apparatus comprises power supply means provided integrally with the housing whereby the apparatus is self-contained and hand holdable.
  • FIG. 1 is a part-sectioned side elevation of a first embodiment of apparatus in accordance with the present invention and having a pointed central electrode;
  • Figure 2 is a part-sectioned side elevation of the second embodiment having a low curvature central electrode and a setaceous outer electrode
  • Figure 3 is an exploded perspective view of a third embodiment comprising an adaptor releasably connectable to a dispensing means.
  • Figure 4 is a part sectioned side elevation of a fourth embodiment which includes a breath sensor and an electrically operated dispenser,
  • Figure 5 is a part sectioned side elevation of a fifth embodiment having a breath sensor and an alternative electrically operated dispenser
  • Figure 6 is a schematic diagram showing the operation of a mechanically actuated dispenser with a displacement sensor
  • Figure 7 is a schematic diagram showing the operation of an apparatus including an actuation sensing switch and a timer, and
  • Figure 8 is a schematic diagram illustrating the operation of an apparatus having a breath sensor and a control circuit including a timer.
  • a first apparatus shown in Figure 1 comprises a housing 2 having a socket portion 3 defining a cylindrical socket 4 in which is slidably received a pressurised dispensing container 5.
  • the pressurised dispensing container 5 has a tubular valve stem 6 through which a metered dose of a liquid droplet aerosol is dispensed when the container is moved relative to the stem, the stem being fixedly received in an actuator 7 defining a nozzle 8 through which the aerosol is directed.
  • the housing 2 further comprises a tubular mouthpiece 9 defining a passageway 10 communicating at one end with an inhalation port 11 and at its other end with air inlet openings 12 admitting air to the passageway from the socket 4.
  • a frusto-conical baffle 13 is located within the passageway 10 such that a first end 14 of small diameter is presented to the nozzle 8 and a second end 15 of larger diameter extends towards the inhalation port 11 such that aerosol particles propelled from the nozzle 8 are able to pass freely through the baffle 13 and emerge from the inhalation port 11.
  • a first electrode 16 is mounted in the baffle 13 and includes a pointed feature 17 extending axially within the baffle in a direction towards the inhalation port 11.
  • the pointed feature 17 is integrally formed with a transversely extending support arm 18, the support arm and pointed feature being formed of metal sheet and electrically connected by means of a wire 19 to a first terminal 20 of a charging circuit 21.
  • a second electrode 22 which is annular and of smooth configuration is mounted in the baffle 13 at a location intermediate the support arm 18 and the inhalation port 11 such that the pointed feature 17 extends centrally through and at right angles to the second electrode 22.
  • the second electrode 22 is connected by a second wire 23 to a second terminal 24 of the charging circuit 21.
  • the charging circuit 21 together with a power supply battery (not shown) is housed within a further compartment 25 defined by the housing 3.
  • the charging circuit 21 is energised and migrating ions between the first electrode 16 and the second electrode 22 define a charging region indicated schematically by broken lines 26, the charging region being traversed by migrating ions having the same polarity as the first electrode.
  • the pressurised dispensing container 5 is manually depressed relative to the actuator 7 thereby discharging a metered dose of a liquid droplet aerosol from the nozzle 8.
  • the droplets are propelled towards the inhalation port 11 via the baffle 13 and through the passageway 10 and are thereby constrained to pass through the charging region 26.
  • the user inhales through the inhalation port 11 and the aerosol droplets are thereby administered to the respiratory tract of the user.
  • the droplets emerging from the nozzle 8 will carry an inherent level of electrostatic charge which is characteristic of the particular dispenser and will typically depend upon the nature of the propellant fluid, the structure of the valve and the materials with which the liquid comes into contact in being dispensed.
  • the mean level of inherent charge can be measured by known techniques and compared with the optimum level of electrostatic charge required to target a particular site in the respiratory tract, this required level of charge being determined by known methods such as mathematical modelling and clinical trials.
  • the required level of voltage supplied between the first and second electrodes 16 and 22 can be empirically determined by measuring the mean level of electrostatic charge of particles emerging from the inhalation port and adjusting the voltage until the charge level matches the required level to achieve satisfactory deposition at the selected site.
  • the second apparatus 30 also includes a pressurised dispenser container 5 arranged to deliver an aerosol spray of liquid droplets from a nozzle 8 when the container is depressed within a socket 4 of a housing 3.
  • a passageway 10 communicates with the socket 4 and with an inhalation port 11 arranged such that when a user inhales through the port 11 air is drawn through the passageway 10 from the socket 4.
  • the passageway 10 is cylindrical and has an internal cylindrical surface 31 to which is fixed an annular first electrode 16 formed of a setaceous material having a multitude of electrically conductive metallic points 32.
  • Axially disposed within the passageway is a second electrode 22 formed as a flat strip of metal plate formed integrally with a diametrically extending support arm 18.
  • a forward end portion 33 of the second electrode 22 has a smoothly rounded tip 34 located centrally within the first electrode 16.
  • the first and second electrodes 16 and 22 are connected to a charging circuit 21 via respective wires 19 and 23.
  • the charging circuit 21 is energised to apply a d.c. voltage between the first and second electrodes such that corona discharge in the air surrounding the points 32 results in migration of ions having the same polarity as the first electrode in a generally radial pattern towards the second electrode 22.
  • the migrating ions define a charging region indicated generally by broken lines 26 through which aerosol liquid droplets emerging from nozzle 8 are propelled in use prior to being inhaled from the inhalation port 11.
  • FIG. 3 A further alternative apparatus 40 is shown in Figure 3 in which corresponding reference numerals to those of Figure 2 are used where appropriate for corresponding elements.
  • the apparatus 40 is shown in exploded view in which an adaptor 41 is ready to be presented to a dispenser 42 such that a tubular member 43 defining an outlet duct 44 of the dispenser 42 is receivable as a sliding fit within a second tubular member 45 of the adaptor 41 so that when assembled the tubular members 43 and 45 together define a passageway 10.
  • the dispenser 42 is operable to dispense air-borne particles through the passageway 10 when actuated.
  • the adaptor 41 contains first and second electrodes 16 and 22 corresponding to those described with reference to Figure 2 and are connected by wires 19 and 23 to a charging circuit 21 located within a circuit housing 46 formed integrally with the second tubular member 45.
  • the charging circuit 21 contains its own power supply and is thereby self-contained.
  • the adaptor 41 can therefore be disconnected from the dispenser 42 and fitted with a replacement dispenser when required.
  • the dispenser 42 is in this example a powder dispenser operable to dispense a metered dose of powdered medicament which is air-borne on inhaled air.
  • a mouthpiece 9 formed integrally with the second tubular member 45 defines an inhalation port 11 through which air is inhaled in use, the inhaled air being drawn through the tubular member 43 from the dispenser 42 so that when actuated the dispenser delivers air-borne particles to the user.
  • the first and second electrodes 16 and 22 are energised during inhalation so as to create a charging region corresponding to the charging region 16 shown in Figure 2 and by means of which a predetermined level of charge is imparted to the particles prior to inhalation.
  • the dispenser 42 may alternatively be a liquid aerosol dispenser such as the pressurised dispenser container 5 of Figures 1 and 2.
  • the setaceus material constituting the electrode 16 of Figures 2 and 3 may alternatively be formed by a carbon fibre brush.
  • a fourth apparatus 50 is similar to the apparatus 1 of Figure 1 but includes an elongated mouth piece 9 which, in addition to the electrodes 16 and 22, accommodates a breath sensor 51.
  • the breath sensor 51 consists of a piezoelectric membrane 52 which is held by a support member 53 so as to normally lie in contact with a side wall of the mouth piece 9.
  • the support member 53 is generally tubular in shape and fits snuggly within the mouth piece 9.
  • the support member 53 is provided with cut outs such as the cut out 54 visible in Figure 4 through which respective undamped portions of the membrane 52 are exposed, each exposed portion of the membrane being surrounded by an annular clamped portion which is overlaid by the support member and thereby clamped in contact with the side wall of the mouth piece.
  • the membrane 52 is a film of PVDF (polyvinylidene fluoride) material upon which are formed sensor electrodes in a known manner to provide an electrical up signal responsive to flexure of the film.
  • PVDF polyvinylidene fluoride
  • An output lead 55 connects the membrane to an electrically operated valve 56 which is arranged to dispense a metered dose of fluid from a pressurised dispensing container 5 in response to a signal being received from the breath sensor 51.
  • the breath sensor 51 is also connected by output leads 57 to terminals 58 of the charging circuit 21 which is configured so as to generate a voltage applied to the electrodes only in response to a signal received from the breath sensor.
  • the charging circuit 21 also includes a timer programmed to measure a predetermined time interval during which the voltage is maintained before deactivating the circuit. In this way, the charging circuit 21 is energised only when required i.e. during inhalation as sensed by the breath sensor 51.
  • the electrically operated valve 56 is similarly arranged to be actuated in response to inhalation being sensed by the breath sensor 51.
  • the piezoelectric membrane 52 will flex at the initiation of inhalation, at which time there is a pronounced pressure change within the passageway, with the result that actuation of the valve 56 occurs at the initial stages of inhalation. This is particularly advantageous when it is required for the dose to be delivered deep into the lungs of the patient who is inhaling.
  • the valve 56 will typically be opened during a period which is very short compared with the length of time taken for a single breath to be taken, a typical time being in the range 0.1 to 0.3 seconds during which time the dose is progressively dispensed into the passageway.
  • Figure 5 illustrates a fifth apparatus 60 which includes a first electrode 16 formed of seteceous material 32 in a manner similar to that described with reference to Figrue 2.
  • the apparatus 60 also includes a breath sensor 51 of the type described with reference to Figure 4 and similarly connected to the charging circuit 21.
  • the sensor 51 is also connected to an electrically operated actuator 61 arranged to longitudinally displace a pressurised dispensing container 5 relative to its associates valve stem 6 such that, on receipt of an actuating signal from the sensor 51, the actuator 61 displaces the container 5 thereby actuating a metering valve 62.
  • the discharge of a metered dose of fluid in the form of droplets or powder can thereby be timed to coincide with the initiation of inhalation as sensed by the breath sensor 51.
  • the dose is dispersed within the passageway so as to be entrained in the inhaled air and passes through a charging region 26 where the charge carried by the airborne particles is modified in a predetermined manner prior to inhalation.
  • FIG. 6 illustrates schematically a sixth apparatus 71 in which a pressurised dispensing container is manually actuated by relative movement between the container and a fixed actuator 7 defining a nozzle 8, there being provided a mechanical switch 72 arranged to sense displacement of the container 5 relative to the housing 6 to which the switch is mounted.
  • the switch 72 is connected to the charging circuit and arranged to actuate the circuit whenever the container 5 is displaced. In this way the application of voltage to the electrodes 16,22 is synchronised with the dispensing action so that the charging region 26 is established simultaneously with the dispersal of the dose into the passageway.
  • this arrangement may be modified by including a timer in the charging circuit 21, the timer being arranged to prolong the activation of the charging circuit for a predetermined time interval which is greater than the period required for inhalation of the dose.
  • the charging circuit is thereby deactivated thereby prolonging the working life of battery 73 used to power the charging circuit.
  • Figure 8 illustrates schematically a further arrangement particularly suitable for use with breath sensors of the PVDF type as described with reference to Figure 4 and 5 and where the sensor generates a voltage pulse by piezoelectric action.
  • a control circuit 74 is connected to the breath sensor and arranged to detect any such voltage pulse.
  • the control circuit is arranged to discriminate between piezoelectrically generated pulses of different polarity so as to respond only to inhalation and not to exhalation effects on the membrane.
  • the control circuit may be used simply to actuate the charging circuit or optionally, as described above with reference to the embodiments of Figures 4 and 5, may be used to also actuate an electrically operable actuator 56 or 61 respectively.
  • the control circuit will typically include a timer arranged to extend actuation of the charging circuit for a predetermined period.

Abstract

A housing defines a passageway having a mouth piece at one end and through which air is inhalable through the passageway, a dispenser being connected to the housing and operable to dispense a metered dose of aerosol liquid or powder. Electrodes (16, 22) are located intermediate the dispenser and the mouth piece and define a charging region (26). A charging circuit (21) applies a voltage across the electrodes, one of which has a pointed feature, such that particles passing through the charging region acquire charge of a predetermined polarity. A breath sensor (51) is used to co-ordinate operation of the charging circuit with the inhalation of the dose. The site of deposition of inhaled particles within the respiratory tract can thereby be influenced by selecting the magnitude and polarity of the voltage applied to the electrodes.

Description

"INHALATION APPARATUS"
This invention relates to inhalation apparatus for dispensing an inhalable substance and in particular but not exclusively to apparatus for use in the delivery of therapeutic substances to the human lung.
Medicinal inhalers are well-known and have made a significant contribution to ailments such as asthma. Of particular usefulness are handheld metered dose inhalers and dry powder inhalers. Each produces an aerosol of fine particles containing medicament and which are carried into the respiratory system as the user inhales. Several factors are known to affect the site at which deposition of such airborne particles are deposited in the respiratory system. Recent research has revealed that the electrostatic charge on the particles plays a very important part in determining the site of deposition and it has been shown that the level of electrostatic charge can be used to control specifically the site of deposition.
A site may thereby be selected to be higher or lower in the bronchial tree to meet requirements of a particular therapeutic or diagnostic procedure. A level of charge can also serve to reduce the amount of particles lost through exhalation and this is particularly important where small quantities of medicament are to be delivered. It is an object of the present invention to provide an apparatus which provides for an inhalable substance to be dispensed in a manner in which the electrostatic charge on the dispensed particles can be controlled in order to target a specific deposition site in the respiratory tract of the user. According to the present invention there is disclosed apparatus for dispensing an inhalable substance comprising a housing defining a passageway, the housing having a mouth piece defining an inhalation port at one end of the passageway and through which a flow of air from the passageway is inhalable in use, a dispensing means connected to the housing and operable to dispense the substance into the passageway at a dispensing location in the form of inhalable particles and charging means defining a charging region of the passageway located intermediate the inhalation port and the dispensing location the charging means comprising a first electrode having at least one pointed feature having a relatively high curvature and located in the passageway, a second electrode having co-operating features of relatively low curvature and located in the passageway and a charging circuit operable to apply a predetermined voltage between the electrodes such that a predetermined polarity is applied to the first electrode whereby the charging means is operable to impart electrostatic charge of predetermined polarity to the particles passing through the charging region, and wherein the dispensing means comprises a metered dose dispenser operable to dispense .a metered dose of the substance. The electrostatic charge characteristically imparted to particles on being dispensed from a given dispensing means can thereby be modified in a controlled manner by imparting further electrostatic charges to the particles as they pass through the charging region before being inhaled.
A controlled level of electrostatic charge thereby inhaled may represent an increase in electrostatic charge as compared with the inherent level of charge, or it may involve a decrease in the charge, a neutralisation or a charge reversal. Such an arrangement of electrodes results in ionised field charging of particles passing through the charging region. Corona disharge in the vicinity of the high curvature pointed feature of the first electrode results in formation of ions of both polarities, those ions having the same polarity as the first electrode being confined by electrostatic attraction to the immediate vicinity of the first electrode and the ions of opposite polarity tending to migrate towards the second electrode. The migrating ions are hence unipolar and the particles colliding with such ions will acquire electrostatic charge of the same polarity as those ions i.e. the predetermined polarity of the first electrode. The first electrode may comprise a setaceous electrode having a multitude of points.
Conveniently the first electrode may comprise a carbon fibre brush.
Conveniently one or other of the electrodes is centrally located with respect to the passageway and the other of the electrodes being peripherally located with respect to the passageway whereby a radial migration of ions is established in use between the electrodes such that a region traversed by the migrating ions constitutes the charging region.
The first electrode may be peripherally located and may constitute a setaceous electrode.
The charging circuit may comprise a voltage control circuit operable to control the voltage applied between the electrodes to a predetermined level associated with a required mean level of charge to be imparted in use to the particles.
Typically the voltage will lie in the range 1 to 10 kvolts and will be selected according to the electrode geometry and spacing.
Conveniently the charging circuit comprises a timing circuit operable to apply the voltage between the electrodes for a predetermined time interval in response to an actuating signal.
The predetermined time interval is selected to be greater than the time taken for the inhalable substance to be dispensed from the dispensing means into the passageway and for subsequent inhalation to be completed.
The housing, the charging means and the mouthpiece may if required together constitute an adaptor releasably connectible to the dispensing means.
The apparatus may include a breath sensor mounted in the passageway for sensing the inhalation of breath through the passageway and operatively connected to the charging circuit whereby the charging circuit is activated and the voltage is applied to the electrodes in response to inhalation being sensed. The period during which the charging circuit is energised may thereby be kept to a minimum in order to conserve power, this being particularly important where the apparatus is a hand held device including an integral power supply. The dispenser may comprise an electrically operated actuating means which is operatively connected to the breath sensor whereby in use the dispenser is actuated to dispense a dose of the substance in response to inhalation being sensed. This is particularly important when adminstering a substance intended to be deposited deep within the lungs of a patient. Under these conditions it is important that the dispensed dose is discharged so as to be inhaled at the beginning of the breath cycle, the typical time during which discharge proceeds being 0.1 to 0.3 seconds for a metered dose inhaler of the pressurised dispenser type. If the dose is released early during inspiration then the probability of the particles reaching the alveolar regions is increased whereas if the release of the dose is during the latter part of the cycle, the particles will tend to be deposited predominantly in the upper airways with much of the dose being lost during exhalation. The additional benefit of modifying the charge associated with the particles provides an additional means of targeting a particular region of the lung. For particles of a given size and type, the preferred net charge per particle can be determined by empirical or modelling techniques and the magnitude and polarity of voltage applied to the electrodes of the apparatus may thereby be adjusted accordingly.
The use of the apparatus thereby enables the substance to be administered in a localised manner with minimal loss from exhalation. Conveniently the breath sensor comprises a membrane of piezoelectric material supported relative to the housing by a support arranged such that the membrane flexes in response to a change of air presure in the passageway and thereby generates a signal representative of inhalation being sensed. Such membrane sensors are known from GB-A-2266466.
The apparatus may comprise a dispenser which is mechanically actuatable by displacement of an actuating member relative to the housing and may comprise a displacement sensor operatively connected to the charging circuit and responsive to displacement of the actuating member whereby the charging circuit is actuated and the voltage is applied to the electrodes in response to displacement being sensed. Synchronisation between the dispensing of the dose and the charging of the electrodes may thereby be achieved in a straightforward manner.
Conveniently where the dispenser comprises a pressurised dispensing container having a dispensing valve stem and a metering valve actuated by relative movement between the valve stem and the container, the container may constitute the actuating member and the displacement sensor may comprise a switch responsive to movement of the container relative to the housing.
The charging circuit may comprise a timing circuit operable to apply the voltage between the electrodes for a predetermined time interval. This is particularly useful when used in conjunction with a breath sensor of the piezoelectric type where the sensor generates an electrical impulse in response to a change of pressure at the beginning of inhalation rather than a sustained pulse throughout the duration of inhalation.
The dispensing means may be operable to dispense particles in the form of liquid droplets or alternatively in the form of a powder.
Preferably the apparatus comprises power supply means provided integrally with the housing whereby the apparatus is self-contained and hand holdable.
Preferred embodiments of the present invention will now be described by way of example only and with reference to the accompanying drawings of which: - Figure 1 is a part-sectioned side elevation of a first embodiment of apparatus in accordance with the present invention and having a pointed central electrode;
Figure 2 is a part-sectioned side elevation of the second embodiment having a low curvature central electrode and a setaceous outer electrode, Figure 3 is an exploded perspective view of a third embodiment comprising an adaptor releasably connectable to a dispensing means.
Figure 4 is a part sectioned side elevation of a fourth embodiment which includes a breath sensor and an electrically operated dispenser,
Figure 5 is a part sectioned side elevation of a fifth embodiment having a breath sensor and an alternative electrically operated dispenser, Figure 6 is a schematic diagram showing the operation of a mechanically actuated dispenser with a displacement sensor,
Figure 7 is a schematic diagram showing the operation of an apparatus including an actuation sensing switch and a timer, and
Figure 8 is a schematic diagram illustrating the operation of an apparatus having a breath sensor and a control circuit including a timer.
A first apparatus shown in Figure 1 comprises a housing 2 having a socket portion 3 defining a cylindrical socket 4 in which is slidably received a pressurised dispensing container 5. The pressurised dispensing container 5 has a tubular valve stem 6 through which a metered dose of a liquid droplet aerosol is dispensed when the container is moved relative to the stem, the stem being fixedly received in an actuator 7 defining a nozzle 8 through which the aerosol is directed.
The housing 2 further comprises a tubular mouthpiece 9 defining a passageway 10 communicating at one end with an inhalation port 11 and at its other end with air inlet openings 12 admitting air to the passageway from the socket 4.
A frusto-conical baffle 13 is located within the passageway 10 such that a first end 14 of small diameter is presented to the nozzle 8 and a second end 15 of larger diameter extends towards the inhalation port 11 such that aerosol particles propelled from the nozzle 8 are able to pass freely through the baffle 13 and emerge from the inhalation port 11.
A first electrode 16 is mounted in the baffle 13 and includes a pointed feature 17 extending axially within the baffle in a direction towards the inhalation port 11. The pointed feature 17 is integrally formed with a transversely extending support arm 18, the support arm and pointed feature being formed of metal sheet and electrically connected by means of a wire 19 to a first terminal 20 of a charging circuit 21. A second electrode 22 which is annular and of smooth configuration is mounted in the baffle 13 at a location intermediate the support arm 18 and the inhalation port 11 such that the pointed feature 17 extends centrally through and at right angles to the second electrode 22.
The second electrode 22 is connected by a second wire 23 to a second terminal 24 of the charging circuit 21.
The charging circuit 21 together with a power supply battery (not shown) is housed within a further compartment 25 defined by the housing 3.
In use the charging circuit 21 is energised and migrating ions between the first electrode 16 and the second electrode 22 define a charging region indicated schematically by broken lines 26, the charging region being traversed by migrating ions having the same polarity as the first electrode. The pressurised dispensing container 5 is manually depressed relative to the actuator 7 thereby discharging a metered dose of a liquid droplet aerosol from the nozzle 8. The droplets are propelled towards the inhalation port 11 via the baffle 13 and through the passageway 10 and are thereby constrained to pass through the charging region 26. At the same time as actuating the pressurised dispensing container 5 the user inhales through the inhalation port 11 and the aerosol droplets are thereby administered to the respiratory tract of the user. The droplets emerging from the nozzle 8 will carry an inherent level of electrostatic charge which is characteristic of the particular dispenser and will typically depend upon the nature of the propellant fluid, the structure of the valve and the materials with which the liquid comes into contact in being dispensed. The mean level of inherent charge can be measured by known techniques and compared with the optimum level of electrostatic charge required to target a particular site in the respiratory tract, this required level of charge being determined by known methods such as mathematical modelling and clinical trials.
The required level of voltage supplied between the first and second electrodes 16 and 22 can be empirically determined by measuring the mean level of electrostatic charge of particles emerging from the inhalation port and adjusting the voltage until the charge level matches the required level to achieve satisfactory deposition at the selected site. A second apparatus will now be described with reference to Figure 2 using corresponding reference numerals to those of Figure 1 where appropriate for corresponding elements.
The second apparatus 30 also includes a pressurised dispenser container 5 arranged to deliver an aerosol spray of liquid droplets from a nozzle 8 when the container is depressed within a socket 4 of a housing 3.
A passageway 10 communicates with the socket 4 and with an inhalation port 11 arranged such that when a user inhales through the port 11 air is drawn through the passageway 10 from the socket 4.
The passageway 10 is cylindrical and has an internal cylindrical surface 31 to which is fixed an annular first electrode 16 formed of a setaceous material having a multitude of electrically conductive metallic points 32.
Axially disposed within the passageway is a second electrode 22 formed as a flat strip of metal plate formed integrally with a diametrically extending support arm 18.
A forward end portion 33 of the second electrode 22 has a smoothly rounded tip 34 located centrally within the first electrode 16.
The first and second electrodes 16 and 22 are connected to a charging circuit 21 via respective wires 19 and 23.
In use the charging circuit 21 is energised to apply a d.c. voltage between the first and second electrodes such that corona discharge in the air surrounding the points 32 results in migration of ions having the same polarity as the first electrode in a generally radial pattern towards the second electrode 22.
The migrating ions define a charging region indicated generally by broken lines 26 through which aerosol liquid droplets emerging from nozzle 8 are propelled in use prior to being inhaled from the inhalation port 11.
A further alternative apparatus 40 is shown in Figure 3 in which corresponding reference numerals to those of Figure 2 are used where appropriate for corresponding elements.
The apparatus 40 is shown in exploded view in which an adaptor 41 is ready to be presented to a dispenser 42 such that a tubular member 43 defining an outlet duct 44 of the dispenser 42 is receivable as a sliding fit within a second tubular member 45 of the adaptor 41 so that when assembled the tubular members 43 and 45 together define a passageway 10. The dispenser 42 is operable to dispense air-borne particles through the passageway 10 when actuated.
The adaptor 41 contains first and second electrodes 16 and 22 corresponding to those described with reference to Figure 2 and are connected by wires 19 and 23 to a charging circuit 21 located within a circuit housing 46 formed integrally with the second tubular member 45.
The charging circuit 21 contains its own power supply and is thereby self-contained. The adaptor 41 can therefore be disconnected from the dispenser 42 and fitted with a replacement dispenser when required.
The dispenser 42 is in this example a powder dispenser operable to dispense a metered dose of powdered medicament which is air-borne on inhaled air. A mouthpiece 9 formed integrally with the second tubular member 45 defines an inhalation port 11 through which air is inhaled in use, the inhaled air being drawn through the tubular member 43 from the dispenser 42 so that when actuated the dispenser delivers air-borne particles to the user. The first and second electrodes 16 and 22 are energised during inhalation so as to create a charging region corresponding to the charging region 16 shown in Figure 2 and by means of which a predetermined level of charge is imparted to the particles prior to inhalation. The dispenser 42 may alternatively be a liquid aerosol dispenser such as the pressurised dispenser container 5 of Figures 1 and 2.
The setaceus material constituting the electrode 16 of Figures 2 and 3 may alternatively be formed by a carbon fibre brush.
Further alternative apparatus will now be described with reference to Figures 4 to 8 using corresponding reference numerals to those of preceding Figures where appropriate for corresponding elements.
In Figure 4 a fourth apparatus 50 is similar to the apparatus 1 of Figure 1 but includes an elongated mouth piece 9 which, in addition to the electrodes 16 and 22, accommodates a breath sensor 51.
The breath sensor 51 consists of a piezoelectric membrane 52 which is held by a support member 53 so as to normally lie in contact with a side wall of the mouth piece 9. The support member 53 is generally tubular in shape and fits snuggly within the mouth piece 9. The support member 53 is provided with cut outs such as the cut out 54 visible in Figure 4 through which respective undamped portions of the membrane 52 are exposed, each exposed portion of the membrane being surrounded by an annular clamped portion which is overlaid by the support member and thereby clamped in contact with the side wall of the mouth piece.
The membrane 52 is a film of PVDF (polyvinylidene fluoride) material upon which are formed sensor electrodes in a known manner to provide an electrical up signal responsive to flexure of the film.
An output lead 55 connects the membrane to an electrically operated valve 56 which is arranged to dispense a metered dose of fluid from a pressurised dispensing container 5 in response to a signal being received from the breath sensor 51.
The breath sensor 51 is also connected by output leads 57 to terminals 58 of the charging circuit 21 which is configured so as to generate a voltage applied to the electrodes only in response to a signal received from the breath sensor. The charging circuit 21 also includes a timer programmed to measure a predetermined time interval during which the voltage is maintained before deactivating the circuit. In this way, the charging circuit 21 is energised only when required i.e. during inhalation as sensed by the breath sensor 51.
The electrically operated valve 56 is similarly arranged to be actuated in response to inhalation being sensed by the breath sensor 51. The piezoelectric membrane 52 will flex at the initiation of inhalation, at which time there is a pronounced pressure change within the passageway, with the result that actuation of the valve 56 occurs at the initial stages of inhalation. This is particularly advantageous when it is required for the dose to be delivered deep into the lungs of the patient who is inhaling. The valve 56 will typically be opened during a period which is very short compared with the length of time taken for a single breath to be taken, a typical time being in the range 0.1 to 0.3 seconds during which time the dose is progressively dispensed into the passageway. Figure 5 illustrates a fifth apparatus 60 which includes a first electrode 16 formed of seteceous material 32 in a manner similar to that described with reference to Figrue 2. The apparatus 60 also includes a breath sensor 51 of the type described with reference to Figure 4 and similarly connected to the charging circuit 21. The sensor 51 is also connected to an electrically operated actuator 61 arranged to longitudinally displace a pressurised dispensing container 5 relative to its associates valve stem 6 such that, on receipt of an actuating signal from the sensor 51, the actuator 61 displaces the container 5 thereby actuating a metering valve 62. The discharge of a metered dose of fluid in the form of droplets or powder can thereby be timed to coincide with the initiation of inhalation as sensed by the breath sensor 51.
The dose is dispersed within the passageway so as to be entrained in the inhaled air and passes through a charging region 26 where the charge carried by the airborne particles is modified in a predetermined manner prior to inhalation.
Figure 6 illustrates schematically a sixth apparatus 71 in which a pressurised dispensing container is manually actuated by relative movement between the container and a fixed actuator 7 defining a nozzle 8, there being provided a mechanical switch 72 arranged to sense displacement of the container 5 relative to the housing 6 to which the switch is mounted. The switch 72 is connected to the charging circuit and arranged to actuate the circuit whenever the container 5 is displaced. In this way the application of voltage to the electrodes 16,22 is synchronised with the dispensing action so that the charging region 26 is established simultaneously with the dispersal of the dose into the passageway. As illustrated schematically in Figure 7, this arrangement may be modified by including a timer in the charging circuit 21, the timer being arranged to prolong the activation of the charging circuit for a predetermined time interval which is greater than the period required for inhalation of the dose. During storage and between actuations of the apparatus in use, the charging circuit is thereby deactivated thereby prolonging the working life of battery 73 used to power the charging circuit.
Figure 8 illustrates schematically a further arrangement particularly suitable for use with breath sensors of the PVDF type as described with reference to Figure 4 and 5 and where the sensor generates a voltage pulse by piezoelectric action. A control circuit 74 is connected to the breath sensor and arranged to detect any such voltage pulse. The control circuit is arranged to discriminate between piezoelectrically generated pulses of different polarity so as to respond only to inhalation and not to exhalation effects on the membrane. The control circuit may be used simply to actuate the charging circuit or optionally, as described above with reference to the embodiments of Figures 4 and 5, may be used to also actuate an electrically operable actuator 56 or 61 respectively. The control circuit will typically include a timer arranged to extend actuation of the charging circuit for a predetermined period.

Claims

CLAIMS :
1. Apparatus (1,30,40,50,60,71) for dispensing an inhalable substance comprising a housing (2) defining a passageway (10) , the housing having a mouth piece (9) defining an inhalation port (11) at one end of the passageway and through which a flow of air from the passageway is inhalable in use, a dispensing means (5) connected to the housing and operable to dispense the substance into the passageway at a dispensing location (8) in the form of inhalable particles and charging means (21,16,22) defining a charging region (26) of the passageway located intermediate the inhalation port and the dispensing location the charging means comprising a first electrode (16) having at least one pointed feature (17,32) having a relatively high curvature and located in the passageway, a second electrode (22) having co-operating features of relatively low curvature and located in the passageway and a charging circuit (21) operable to apply a predetermined voltage between the electrodes such that a predetermined polarity is applied to the first electrode whereby the charging means is operable to impart electrostatic charge of predetermined polarity to the particles passing through the charging region, and wherein the dispensing means comprises a metered dose dispenser (5) operable to dispense a metered dose of the substance.
2. Apparatus as claimed in claim 1 wherein the first electrode is a setaceous electrode having a multitude of points (32) .
3. Apparatus as claimed in claim 2 wherein the first electrode comprises a carbon fibre brush.
4. Apparatus as claimed in claim 1 wherein one or other of the electrodes is centrally located with respect to the passageway and the other of the electrodes is peripherally located with respect to the passageway whereby a radial migration of ions is established in use between the electrodes such that a region traversed by the migrating ions constitutes the charging region.
5. Apparatus as claimed in claim 4 wherein the first electrode is peripherally located and constitutes a setaceous electrode.
6. Apparatus as claimed in any preceding claim wherein the charging circuit is operable to control the voltage applied between the electrodes to a predetermined level associated with a required mean level of charge to be imparted in use to the particles.
7. Apparatus as claimed in claim 6 wherein the voltage is in the range 1 to 10 kvolts.
8. Apparatus as claimed in any preceding claim comprising a breath sensor (51) mounted in the passageway for sensing the inhalation of breath through the passageway and operatively connected to the charging circuit whereby the charging circuit is activated and the voltage is applied to the electrodes in response to inhalation being sensed.
9. Apparatus as claimed in claim 8 wherein the dispenser comprises electrically operated actuating means (56,61) operatively connected to the sensor whereby in use the dispenser is actuated to dispense a dose of the substance in response to inhalation being sensed.
10. Apparatus as claimed in any of claims 8 and 9 wherein the breath sensor comprises a membrane (52) of piezoelectric material supported relative to the housing by a support (53) arranged such that the membrane flexes in response to a change of air pressure in the passageway and thereby generate a signal representative of inhalation being sensed.
11. Apparatus as claimed in any of claims 1 to 10 wherein the dispenser is mechanically actuatable by displacement of an actuating member (5) relative to the housing and comprising a displacement sensor (72) operatively connected to the charging circuit and responsive to displacement of the actuating member whereby the charging circuit is actuated and the voltage is applied to electrodes in response to displacement being sensed.
12. Apparatus as claimed in claim 11 wherein the dispenser comprises a pressurised dispensing container (5) having a dispensing valve stem (6) and a metering valve (62) actuated by relative movement between the valve stem and the container, wherein the container constitutes the actuating member and the displacement sensor comprises a switch responsive to movement of the container relative to the housing.
13. Apparatus as claimed in any of claims 8 to
12 wherein the charging circuit comprises a timing circuit operable to apply the voltage between the electrodes for a predetermined time interval.
14. Apparatus as claimed in any preceding claim wherein the housing, the charging means and the mouthpiece together constitute an adaptor (41) releasably connectible to the dispenser.
15. Apparatus as claimed in any preceding claim wherein the dispenser is operable to dispense particles in the form of liquid droplets.
16. Apparatus as claimed in any of claims 1 to 9 wherein the dispenser is operable to dispense particles in the form of a powder.
17. Apparatus as claimed in any preceding claim further comprising power supply means (73) provided integrally with the housing whereby the apparatus is self-contained and hand holdable.
PCT/GB1994/000338 1993-02-19 1994-02-21 Inhalation apparatus WO1994019042A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP94906960A EP0684852A1 (en) 1993-02-19 1994-02-21 Inhalation apparatus

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939303335A GB9303335D0 (en) 1993-02-19 1993-02-19 Inhalation apparatus
GB9303335.5 1993-02-19

Publications (1)

Publication Number Publication Date
WO1994019042A1 true WO1994019042A1 (en) 1994-09-01

Family

ID=10730690

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB1994/000338 WO1994019042A1 (en) 1993-02-19 1994-02-21 Inhalation apparatus

Country Status (3)

Country Link
EP (1) EP0684852A1 (en)
GB (1) GB9303335D0 (en)
WO (1) WO1994019042A1 (en)

Cited By (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995032807A1 (en) * 1994-05-27 1995-12-07 Electrosols Ltd. Dispensing device
WO1996010459A2 (en) * 1994-10-04 1996-04-11 Imperial Chemical Industries Plc Electrostatic spraying of particulate material
EP0722746A1 (en) * 1995-01-21 1996-07-24 Dieter Prof. Dr. med. KÖHLER Device for generating an aerosol using a powdery substance
WO1996040441A1 (en) * 1995-06-07 1996-12-19 Imperial Chemical Industries Plc Electrostatic spraying
WO1997000704A1 (en) * 1995-06-21 1997-01-09 Lars Gunnar Nilsson A device for an inhaler
US5593456A (en) * 1994-05-17 1997-01-14 Crp, Inc. Foot and leg prosthesis and method of making same
FR2742056A1 (en) * 1995-12-12 1997-06-13 Blanc Philippe Portable aerosol generator, e.g. for medical nebuliser
WO1997026934A2 (en) * 1996-01-25 1997-07-31 Abrams Andrew L Inhalation device
WO1999021659A1 (en) * 1997-10-28 1999-05-06 Reckitt & Colman Products Limited Compressed gas propelled aerosol devices
GB2334461A (en) * 1998-02-20 1999-08-25 Bespak Plc Inhalation apparatus
WO2000001494A1 (en) * 1998-07-02 2000-01-13 University Of Southampton Inhalation of aerosol actives
US6079634A (en) * 1996-05-30 2000-06-27 The Procter & Gamble Company Electrostatic spraying
WO2000038770A2 (en) * 1998-12-23 2000-07-06 Battelle Memorial Institute Pulmonary aerosol delivery device and method
US6142146A (en) * 1998-06-12 2000-11-07 Microdose Technologies, Inc. Inhalation device
US6152130A (en) * 1998-06-12 2000-11-28 Microdose Technologies, Inc. Inhalation device with acoustic control
WO2001085243A1 (en) * 2000-05-05 2001-11-15 Ml Laboratories Plc Inhalation chamber
WO2001085240A1 (en) * 2000-05-03 2001-11-15 Michael Anthony Dellavecchia Ultrasonic dosage device and method
US6457470B1 (en) * 1992-12-22 2002-10-01 Electrosols Ltd. Dispensing device
WO2002087673A1 (en) * 2001-04-25 2002-11-07 Messer Austria Gmbh Aerosol dosing device
US6595208B1 (en) * 1997-08-08 2003-07-22 Battelle Memorial Institute Dispensing device
WO2006032889A1 (en) * 2004-09-25 2006-03-30 Scion-Sprays Limited Electrostatic atomisers and mixing arrangements
US20070240707A1 (en) * 2003-12-19 2007-10-18 Valois S.A.S Fluid Product Dispensing Device
WO2008084269A2 (en) * 2007-01-12 2008-07-17 Janos Feher Device for producing rich in nacl, high dispersity and low moisture aerosol
US7607435B2 (en) 2004-01-21 2009-10-27 Battelle Memorial Institute Gas or liquid flow sensor
EP2221079A1 (en) * 2009-02-18 2010-08-25 Ing. Erich Pfeiffer GmbH Dispensing device for dispensing a pharmaceutical liquid in atomised form
WO2013114373A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Inhalable liquid formulations of dnase i
US9114221B2 (en) 2009-03-10 2015-08-25 Euro-Celtique S.A. Counter
RU2565814C2 (en) * 2013-05-29 2015-10-20 Алексей Алексеевич Палей Method of disperse aerosol formation and device for its realisation
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
WO2016057693A1 (en) 2014-10-10 2016-04-14 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
US9415178B2 (en) 2009-03-10 2016-08-16 Euro-Celtique S.A. Counter
CN106031809A (en) * 2015-03-12 2016-10-19 昆山科技大学 A medicine mist inhaling assisting device structure
US9592355B2 (en) 2005-09-09 2017-03-14 Raymond John Bacon Dispenser
US9707360B2 (en) 2004-11-19 2017-07-18 Clinical Designs Limited Substance source
CN109803549A (en) * 2016-10-12 2019-05-24 日本烟草产业株式会社 Fragrance inhalator
KR20220010761A (en) * 2018-04-25 2022-01-26 주식회사 케이티앤지 Aerosol inhaler

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1045883A (en) * 1963-04-17 1966-10-19 Simonne June Kerr Inspiration apparatus
US4228961A (en) * 1979-05-07 1980-10-21 Onoda Cement Co., Ltd. Electrostatic power painting head
FR2605249A1 (en) * 1986-10-17 1988-04-22 Gauchard Fernand Aerosol generator
WO1990003224A1 (en) * 1988-09-23 1990-04-05 Battelle Memorial Institute Nebulizer device
US4971257A (en) * 1989-11-27 1990-11-20 Marc Birge Electrostatic aerosol spray can assembly
EP0448204A1 (en) * 1990-02-20 1991-09-25 Pauline L. Dessertine Inhaler device with counter and timer means
GB2266466A (en) * 1992-04-08 1993-11-03 Bespak Plc Inhalation apparatus

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1045883A (en) * 1963-04-17 1966-10-19 Simonne June Kerr Inspiration apparatus
US4228961A (en) * 1979-05-07 1980-10-21 Onoda Cement Co., Ltd. Electrostatic power painting head
FR2605249A1 (en) * 1986-10-17 1988-04-22 Gauchard Fernand Aerosol generator
WO1990003224A1 (en) * 1988-09-23 1990-04-05 Battelle Memorial Institute Nebulizer device
US4971257A (en) * 1989-11-27 1990-11-20 Marc Birge Electrostatic aerosol spray can assembly
EP0448204A1 (en) * 1990-02-20 1991-09-25 Pauline L. Dessertine Inhaler device with counter and timer means
GB2266466A (en) * 1992-04-08 1993-11-03 Bespak Plc Inhalation apparatus

Cited By (67)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6457470B1 (en) * 1992-12-22 2002-10-01 Electrosols Ltd. Dispensing device
US5593456A (en) * 1994-05-17 1997-01-14 Crp, Inc. Foot and leg prosthesis and method of making same
US5915377A (en) * 1994-05-27 1999-06-29 Electrosols, Ltd. Dispensing device producing multiple comminutions of opposing polarities
WO1995032807A1 (en) * 1994-05-27 1995-12-07 Electrosols Ltd. Dispensing device
WO1996010459A2 (en) * 1994-10-04 1996-04-11 Imperial Chemical Industries Plc Electrostatic spraying of particulate material
WO1996010459A3 (en) * 1994-10-04 1996-05-23 Ici Plc Electrostatic spraying of particulate material
US6138671A (en) * 1994-10-04 2000-10-31 The Procter & Gamble Company Electrostatic spraying of particulate material
EP0722746A1 (en) * 1995-01-21 1996-07-24 Dieter Prof. Dr. med. KÖHLER Device for generating an aerosol using a powdery substance
WO1996040441A1 (en) * 1995-06-07 1996-12-19 Imperial Chemical Industries Plc Electrostatic spraying
AU697654B2 (en) * 1995-06-21 1998-10-15 Microdrug Ag A device for an inhaler
US6089227A (en) * 1995-06-21 2000-07-18 Microdrug Ag Device for an inhaler
WO1997000704A1 (en) * 1995-06-21 1997-01-09 Lars Gunnar Nilsson A device for an inhaler
FR2742056A1 (en) * 1995-12-12 1997-06-13 Blanc Philippe Portable aerosol generator, e.g. for medical nebuliser
WO1997026934A2 (en) * 1996-01-25 1997-07-31 Abrams Andrew L Inhalation device
EP1563864A2 (en) * 1996-01-25 2005-08-17 Microdose Technologies Inc. Inhalation device
EP1563864A3 (en) * 1996-01-25 2010-11-17 MicroDose Therapeutx, Inc. Inhalation device
WO1997026934A3 (en) * 1996-01-25 1997-09-25 Andrew L Abrams Inhalation device
US6079634A (en) * 1996-05-30 2000-06-27 The Procter & Gamble Company Electrostatic spraying
US6595208B1 (en) * 1997-08-08 2003-07-22 Battelle Memorial Institute Dispensing device
US6279834B1 (en) * 1997-10-28 2001-08-28 Reckitt & Colman Products Limited Compressed gas propelled aerosol devices
WO1999021659A1 (en) * 1997-10-28 1999-05-06 Reckitt & Colman Products Limited Compressed gas propelled aerosol devices
GB2334461A (en) * 1998-02-20 1999-08-25 Bespak Plc Inhalation apparatus
US6394086B1 (en) 1998-02-20 2002-05-28 Bespak Plc Inhalation apparatus
WO1999042153A1 (en) 1998-02-20 1999-08-26 Bespak Plc Inhalation apparatus
GB2334461B (en) * 1998-02-20 2002-01-23 Bespak Plc Inhalation apparatus
US6142146A (en) * 1998-06-12 2000-11-07 Microdose Technologies, Inc. Inhalation device
US6152130A (en) * 1998-06-12 2000-11-28 Microdose Technologies, Inc. Inhalation device with acoustic control
CN1106885C (en) * 1998-07-02 2003-04-30 南安普敦大学 Inhalation of aerosol actives
AU751290B2 (en) * 1998-07-02 2002-08-08 Reckitt Benckiser (Uk) Limited Inhalation of aerosol actives
WO2000001494A1 (en) * 1998-07-02 2000-01-13 University Of Southampton Inhalation of aerosol actives
WO2000038770A2 (en) * 1998-12-23 2000-07-06 Battelle Memorial Institute Pulmonary aerosol delivery device and method
WO2000038770A3 (en) * 1998-12-23 2001-08-02 Battelle Memorial Institute Pulmonary aerosol delivery device and method
AU764814B2 (en) * 1998-12-23 2003-08-28 Battelle Memorial Institute Pulmonary aerosol delivery device and method
WO2001085240A1 (en) * 2000-05-03 2001-11-15 Michael Anthony Dellavecchia Ultrasonic dosage device and method
US6748944B1 (en) * 2000-05-03 2004-06-15 Dellavecchia Michael Anthony Ultrasonic dosage device and method
WO2001085243A1 (en) * 2000-05-05 2001-11-15 Ml Laboratories Plc Inhalation chamber
WO2002087673A1 (en) * 2001-04-25 2002-11-07 Messer Austria Gmbh Aerosol dosing device
US20070240707A1 (en) * 2003-12-19 2007-10-18 Valois S.A.S Fluid Product Dispensing Device
US8869791B2 (en) * 2003-12-19 2014-10-28 Aptar France Sas Fluid product dispensing device
US7607435B2 (en) 2004-01-21 2009-10-27 Battelle Memorial Institute Gas or liquid flow sensor
WO2006032889A1 (en) * 2004-09-25 2006-03-30 Scion-Sprays Limited Electrostatic atomisers and mixing arrangements
US9707360B2 (en) 2004-11-19 2017-07-18 Clinical Designs Limited Substance source
US9592355B2 (en) 2005-09-09 2017-03-14 Raymond John Bacon Dispenser
US10369307B2 (en) 2005-09-09 2019-08-06 Clinical Designs Limited Dispenser
WO2008084269A3 (en) * 2007-01-12 2009-02-12 Janos Feher Device for producing rich in nacl, high dispersity and low moisture aerosol
WO2008084269A2 (en) * 2007-01-12 2008-07-17 Janos Feher Device for producing rich in nacl, high dispersity and low moisture aerosol
US9179691B2 (en) 2007-12-14 2015-11-10 Aerodesigns, Inc. Delivering aerosolizable food products
EP2221079A1 (en) * 2009-02-18 2010-08-25 Ing. Erich Pfeiffer GmbH Dispensing device for dispensing a pharmaceutical liquid in atomised form
US9987441B2 (en) 2009-03-10 2018-06-05 Euro-Celtique S.A. Counter
US9114221B2 (en) 2009-03-10 2015-08-25 Euro-Celtique S.A. Counter
US9415178B2 (en) 2009-03-10 2016-08-16 Euro-Celtique S.A. Counter
US9603907B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Dry powder formulations of dNase I
WO2013114371A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Dry powder formulations of dnase i
US9603906B2 (en) 2012-02-01 2017-03-28 Protalix Ltd. Inhalable liquid formulations of DNase I
WO2013114373A1 (en) 2012-02-01 2013-08-08 Protalix Ltd. Inhalable liquid formulations of dnase i
RU2565814C2 (en) * 2013-05-29 2015-10-20 Алексей Алексеевич Палей Method of disperse aerosol formation and device for its realisation
WO2016057693A1 (en) 2014-10-10 2016-04-14 Alnylam Pharmaceuticals, Inc. Methods and compositions for inhalation delivery of conjugated oligonucleotide
CN106031809A (en) * 2015-03-12 2016-10-19 昆山科技大学 A medicine mist inhaling assisting device structure
CN109803549A (en) * 2016-10-12 2019-05-24 日本烟草产业株式会社 Fragrance inhalator
EP3527085A4 (en) * 2016-10-12 2020-06-03 Japan Tobacco Inc. Flavor inhaler
US11202465B2 (en) 2016-10-12 2021-12-21 Japan Tobacco Inc. Flavor inhaler
CN109803549B (en) * 2016-10-12 2022-03-01 日本烟草产业株式会社 Fragrance inhaler
EP3973800A1 (en) * 2016-10-12 2022-03-30 Japan Tobacco Inc. Flavor inhaler
EP3973801A1 (en) * 2016-10-12 2022-03-30 Japan Tobacco Inc. Flavor inhaler
US11864579B2 (en) 2016-10-12 2024-01-09 Japan Tobacco Inc. Flavor inhaler
KR20220010761A (en) * 2018-04-25 2022-01-26 주식회사 케이티앤지 Aerosol inhaler
KR102470618B1 (en) * 2018-04-25 2022-11-25 주식회사 케이티앤지 Aerosol inhaler

Also Published As

Publication number Publication date
GB9303335D0 (en) 1993-04-07
EP0684852A1 (en) 1995-12-06

Similar Documents

Publication Publication Date Title
WO1994019042A1 (en) Inhalation apparatus
AU764814B2 (en) Pulmonary aerosol delivery device and method
KR100314138B1 (en) Metering device
AU759191B2 (en) Improvements in and relating to drug delivery apparatus
US6584971B1 (en) Drug delivery apparatus
EP1154815B1 (en) Piezo inhaler
EP1056497B1 (en) Inhalation apparatus
US7073499B1 (en) Inhaler with airflow regulation
WO1992007599A1 (en) Inhalation device
EP1670531A1 (en) Inhaler with air flow regulation
Zimlich Jr et al. Pulmonary aerosol delivery device and method
AU677081B2 (en) Dispenser
KR20010099950A (en) Pulmonary aerosol delivery device and method
US20200016345A1 (en) Tidal inhaler adaptive dosing
NZ757277B2 (en) Tidal inhaler adaptive dosing

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): CA CN GB US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IE IT LU MC NL PT SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 1994906960

Country of ref document: EP

ENP Entry into the national phase

Ref country code: US

Ref document number: 1995 495454

Date of ref document: 19950728

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 1994906960

Country of ref document: EP

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1994906960

Country of ref document: EP